Published in Am J Pathol on January 01, 2005
A common haplotype in the complement regulatory gene factor H (HF1/CFH) predisposes individuals to age-related macular degeneration. Proc Natl Acad Sci U S A (2005) 13.44
Age-related macular degeneration--emerging pathogenetic and therapeutic concepts. Ann Med (2006) 2.99
Systemic complement activation in age-related macular degeneration. PLoS One (2008) 2.18
Race- and sex-related differences in retinal thickness and foveal pit morphology. Invest Ophthalmol Vis Sci (2011) 1.76
Age-related macular degeneration: genetics and biology coming together. Annu Rev Genomics Hum Genet (2014) 1.69
The potential role of amyloid beta in the pathogenesis of age-related macular degeneration. J Clin Invest (2005) 1.56
Evidence for an inflammatory process in age-related macular degeneration gains new support. Proc Natl Acad Sci U S A (2005) 1.54
Increased expression of multifunctional serine protease, HTRA1, in retinal pigment epithelium induces polypoidal choroidal vasculopathy in mice. Proc Natl Acad Sci U S A (2011) 1.45
Complement, age-related macular degeneration and a vision of the future. Arch Ophthalmol (2010) 1.42
ABCA4-associated retinal degenerations spare structure and function of the human parapapillary retina. Invest Ophthalmol Vis Sci (2005) 1.40
Systems biology-based analysis implicates a novel role for vitamin D metabolism in the pathogenesis of age-related macular degeneration. Hum Genomics (2011) 1.08
Esterified cholesterol is highly localized to Bruch's membrane, as revealed by lipid histochemistry in wholemounts of human choroid. J Histochem Cytochem (2009) 1.04
Treatment with 670 nm light up regulates cytochrome C oxidase expression and reduces inflammation in an age-related macular degeneration model. PLoS One (2013) 1.03
Increased choroidal neovascularization following laser induction in mice lacking lysyl oxidase-like 1. Invest Ophthalmol Vis Sci (2008) 1.01
Sublytic membrane-attack-complex (MAC) activation alters regulated rather than constitutive vascular endothelial growth factor (VEGF) secretion in retinal pigment epithelium monolayers. J Biol Chem (2011) 0.99
The alternative pathway is required, but not alone sufficient, for retinal pathology in mouse laser-induced choroidal neovascularization. Mol Immunol (2011) 0.98
Impaired expression of thrombospondin-1 in eyes with age related macular degeneration. Br J Ophthalmol (2006) 0.97
A novel source of methylglyoxal and glyoxal in retina: implications for age-related macular degeneration. PLoS One (2012) 0.97
Systemic human CR2-targeted complement alternative pathway inhibitor ameliorates mouse laser-induced choroidal neovascularization. J Ocul Pharmacol Ther (2012) 0.96
An update on the ocular phenotype in patients with pseudoxanthoma elasticum. Front Genet (2013) 0.94
Elastin-mediated choroidal endothelial cell migration: possible role in age-related macular degeneration. Invest Ophthalmol Vis Sci (2008) 0.93
Age-related decline in VIP-positive parasympathetic nerve fibers in the human submacular choroid. Invest Ophthalmol Vis Sci (2007) 0.89
Fibulin-5 distribution in human eyes: relevance to age-related macular degeneration. Exp Eye Res (2006) 0.89
Multiplex analysis of age-related protein and lipid modifications in human Bruch's membrane. FASEB J (2010) 0.89
Age-related macular degeneration and changes in the extracellular matrix. Med Sci Monit (2014) 0.88
Adhesion failures determine the pattern of choroidal neovascularization in the eye: a computer simulation study. PLoS Comput Biol (2012) 0.87
Serum levels of matrix metalloproteinase 2 and matrix metalloproteinase 9 elevated in polypoidal choroidal vasculopathy but not in age-related macular degeneration. Mol Vis (2013) 0.85
Changes in fibroblast mechanostat set point and mechanosensitivity: an adaptive response to mechanical stress in floppy eyelid syndrome. Invest Ophthalmol Vis Sci (2010) 0.85
Influence of ROBO1 and RORA on risk of age-related macular degeneration reveals genetically distinct phenotypes in disease pathophysiology. PLoS One (2011) 0.85
CNTF Gene Therapy Confers Lifelong Neuroprotection in a Mouse Model of Human Retinitis Pigmentosa. Mol Ther (2015) 0.85
Polypoidal Choroidal Vasculopathy in Asians. J Clin Med (2015) 0.84
Rare and common variants in extracellular matrix gene Fibrillin 2 (FBN2) are associated with macular degeneration. Hum Mol Genet (2014) 0.84
Influence of age on retinochoroidal healing processes after argon photocoagulation in C57bl/6j mice. Mol Vis (2009) 0.84
Mouse genetics and proteomic analyses demonstrate a critical role for complement in a model of DHRD/ML, an inherited macular degeneration. Hum Mol Genet (2013) 0.83
Topographic and age-related changes of the retinal epithelium and Bruch's membrane of rhesus monkeys. Graefes Arch Clin Exp Ophthalmol (2010) 0.83
Treatment of age-related macular degeneration: beyond VEGF. Jpn J Ophthalmol (2010) 0.83
Heat treatment of retinal pigment epithelium induces production of elastic lamina components and antiangiogenic activity. FASEB J (2011) 0.81
Inhibition of elastin peptide-mediated angiogenic signaling mechanism(s) in choroidal endothelial cells by the α6(IV)NC1 collagen fragment. Invest Ophthalmol Vis Sci (2013) 0.81
Association between systemic arterial stiffness and age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol (2006) 0.81
Molecular responses of choroidal endothelial cells to elastin derived peptides through the elastin-binding protein (GLB1). Matrix Biol (2011) 0.80
A comparison of some organizational characteristics of the mouse central retina and the human macula. PLoS One (2015) 0.80
Studying age-related macular degeneration using animal models. Optom Vis Sci (2014) 0.80
Cathepsin L in bone marrow-derived cells is required for retinal and choroidal neovascularization. Am J Pathol (2010) 0.79
Foveal localization in non-exudative AMD using scanning laser polarimetry. Optom Vis Sci (2012) 0.76
Whole Exome Sequencing in Patients with the Cuticular Drusen Subtype of Age-Related Macular Degeneration. PLoS One (2016) 0.76
Reengineering Human Bruch's Membrane Increases Rod Outer Segment Phagocytosis by Human Retinal Pigment Epithelium. Transl Vis Sci Technol (2015) 0.76
Nitrite Modification of Extracellular Matrix Alters CD46 Expression and VEGF Release in Human Retinal Pigment Epithelium. Invest Ophthalmol Vis Sci (2015) 0.76
Heparanase-1 activities in the development of laser induced choroidal neovascularization. Int J Ophthalmol (2013) 0.75
Can Novel Treatment of Age-Related Macular Degeneration Be Developed by Better Understanding of Sorsby's Fundus Dystrophy. J Clin Med (2015) 0.75
Bruch´s membrane thickness in relationship to axial length. PLoS One (2017) 0.75
Inflammation and Alzheimer's disease. Neurobiol Aging (2000) 12.56
An international classification and grading system for age-related maculopathy and age-related macular degeneration. The International ARM Epidemiological Study Group. Surv Ophthalmol (1995) 10.05
An integrated hypothesis that considers drusen as biomarkers of immune-mediated processes at the RPE-Bruch's membrane interface in aging and age-related macular degeneration. Prog Retin Eye Res (2001) 8.38
Ageing and degeneration in the macular region: a clinico-pathological study. Br J Ophthalmol (1976) 5.73
A role for local inflammation in the formation of drusen in the aging eye. Am J Ophthalmol (2002) 5.57
Risk factors for age-related macular degeneration: Pooled findings from three continents. Ophthalmology (2001) 5.06
Evolution of geographic atrophy of the retinal pigment epithelium. Eye (Lond) (1988) 4.47
Age-related macular degeneration histopathologic studies. The 1992 Lorenz E. Zimmerman Lecture. Ophthalmology (1993) 3.99
Morphometric analysis of Bruch's membrane, the choriocapillaris, and the choroid in aging. Invest Ophthalmol Vis Sci (1994) 3.37
Mutations in the tissue inhibitor of metalloproteinases-3 (TIMP3) in patients with Sorsby's fundus dystrophy. Nat Genet (1994) 3.11
The morphological development of the human fovea. Ophthalmology (1984) 3.08
Immunological and aetiological aspects of macular degeneration. Prog Retin Eye Res (2001) 2.87
Pathologic features of senile macular degeneration. Ophthalmology (1985) 2.73
A potential role for immune complex pathogenesis in drusen formation. Exp Eye Res (2000) 2.58
Accumulation of cholesterol with age in human Bruch's membrane. Invest Ophthalmol Vis Sci (2001) 2.54
VEGF is major stimulator in model of choroidal neovascularization. Invest Ophthalmol Vis Sci (2000) 2.38
Location, substructure, and composition of basal laminar drusen compared with drusen associated with aging and age-related macular degeneration. Am J Ophthalmol (2000) 2.27
Maternal and postnatal vitamin D ingestion influences rat aortic structure, function and elastin content. Cardiovasc Res (2002) 2.24
Bruch's membrane and disease of the macula. Role of elastic tissue and collagen. Trans Ophthalmol Soc U K (1967) 2.05
Basal linear deposit and large drusen are specific for early age-related maculopathy. Arch Ophthalmol (1999) 2.01
Vitronectin is a constituent of ocular drusen and the vitronectin gene is expressed in human retinal pigmented epithelial cells. FASEB J (1999) 2.00
Overexpression of vascular endothelial growth factor (VEGF) in the retinal pigment epithelium leads to the development of choroidal neovascularization. Am J Pathol (2000) 1.93
Macrophages related to Bruch's membrane in age-related macular degeneration. Eye (Lond) (1990) 1.87
Etiology of choroidal neovascularization in young patients. Ophthalmology (1996) 1.74
Clinicopathologic correlation of drusen and retinal pigment epithelial abnormalities in age-related macular degeneration. Retina (1994) 1.72
TIMP-3 in Bruch's membrane: changes during aging and in age-related macular degeneration. Invest Ophthalmol Vis Sci (1999) 1.68
Increase in the advanced glycation end product pentosidine in Bruch's membrane with age. Invest Ophthalmol Vis Sci (1999) 1.67
Age-related variation in the hydraulic conductivity of Bruch's membrane. Invest Ophthalmol Vis Sci (1995) 1.61
Inducible expression of vascular endothelial growth factor in adult mice causes severe proliferative retinopathy and retinal detachment. Am J Pathol (2002) 1.59
Histologic and morphometric analysis of the choroid, Bruch's membrane, and retinal pigment epithelium in postmortem eyes with age-related macular degeneration and histologic examination of surgically excised choroidal neovascular membranes. Surv Ophthalmol (1999) 1.54
Intrachoroidal neovascularization in transgenic mice overexpressing vascular endothelial growth factor in the retinal pigment epithelium. Am J Pathol (2001) 1.53
The association of cataract and cataract surgery with the long-term incidence of age-related maculopathy: the Beaver Dam eye study. Arch Ophthalmol (2002) 1.51
Granulomatous reaction to Bruch's membrane in age-related macular degeneration. Arch Ophthalmol (1994) 1.46
Characteristics of Drusen and Bruch's membrane in postmortem eyes with age-related macular degeneration. Arch Ophthalmol (1997) 1.41
Impaired synthesis of elastin in walls of aorta and large conduit arteries during early development as an initiating event in pathogenesis of systemic hypertension. Lancet (1997) 1.39
Age-related macular degeneration: review of pathogenesis. Eur J Ophthalmol (1999) 1.37
Atherosclerosis: the emerging role of inflammation and the CD40-CD40 ligand system. Proc Natl Acad Sci U S A (2000) 1.36
Ageing changes in Bruch's membrane and their functional implications. Trans Ophthalmol Soc U K (1978) 1.35
Age-related changes in the ultrastructure of Bruch's membrane. Am J Ophthalmol (1985) 1.29
Long-term visual prognosis of choroidal neovascularization in high myopia: a comparison between age groups. Ophthalmology (2002) 1.29
Molecular composition of drusen as related to substructural phenotype. Mol Vis (1999) 1.28
Choroidal neovascularization. Ophthalmology (1986) 1.27
Subretinal neovascularization. Natural history of an experimental model. Arch Ophthalmol (1982) 1.27
Transforming growth factor-beta stimulates wound healing and modulates extracellular matrix gene expression in pig skin. I. Excisional wound model. Lab Invest (1990) 1.25
Studies on the human macula. IV. Aging changes in Bruch's membrane. Arch Ophthalmol (1967) 1.20
Morphologic changes in age-related maculopathy. Microsc Res Tech (1997) 1.19
Menkes' kinky hair disease: a light and electron microscopic study of the eye. Invest Ophthalmol (1976) 1.13
Age-related alterations in the diffusional transport of amino acids across the human Bruch's-choroid complex. J Opt Soc Am A Opt Image Sci Vis (2002) 1.10
An ultrastructural study of the role of leucocytes and fibroblasts in the breakdown of Bruch's membrane. Aust J Ophthalmol (1984) 1.10
Changes in Bruch's membrane and related structures with age. Prog Retin Eye Res (1999) 1.10
The relationships of age changes in retinal pigment epithelium and Bruch's membrane. Invest Ophthalmol Vis Sci (1999) 1.09
Senile macular degeneration. The involvement of giant cells in atrophy of the retinal pigment epithelium. Invest Ophthalmol Vis Sci (1986) 1.05
TIMP-3, collagen, and elastin immunohistochemistry and histopathology of Sorsby's fundus dystrophy. Invest Ophthalmol Vis Sci (2000) 0.99
Iatrogenic choroidal neovascularization. Surv Ophthalmol (1999) 0.97
Choroidal neovascularization can digest Bruch's membrane. A prior break is not essential. Ophthalmology (1984) 0.96
Preparation of Bruch's membrane and analysis of the age-related changes in the structural collagens. Br J Ophthalmol (1995) 0.93
Subfoveal and juxtafoveal subretinal neovascularization in the presumed ocular histoplasmosis syndrome. Visual prognosis. Ophthalmology (1984) 0.92
Ultrastructure of Bruch's membrane after krypton laser photocoagulation. I. Breakdown of Bruch's membrane. Arch Ophthalmol (1986) 0.92
Bruch's membrane age-related changes vary by region. Curr Eye Res (1987) 0.91
Clinicopathological correlation in exudative age-related macular degeneration: recurrent choroidal neovascularization. Graefes Arch Clin Exp Ophthalmol (2001) 0.89
Ocular findings in four siblings with pseudoxanthoma elasticum. Acta Ophthalmol (Copenh) (1983) 0.89
Editorial: Bruch's membrane and vascular growth. Invest Ophthalmol (1976) 0.88
Responses of vascular smooth muscle cell to extracellular matrix degradation. J Cell Biochem (1999) 0.86
Elastin degradation products induce adventitial angiogenesis in the Anidjar/Dobrin rat aneurysm model. Surgery (1997) 0.86
Ocular histoplasmosis: clinicopathologic correlation of 3 cases. Surv Ophthalmol (1978) 0.84
The fine structure of Bruch's membrane in the human eye. Can J Ophthalmol (1969) 0.83
Successful photodynamic therapy for subretinal neovascularisation due to Sorsby's fundus dystrophy: 1 year follow up. Br J Ophthalmol (2003) 0.81
[Biochemical and histochemical analysis of age related lipid deposits in Bruch's membrane]. Ophthalmologe (1994) 0.81
Ultrastructural studies on dermis from prolidase deficient subjects. J Submicrosc Cytol Pathol (1991) 0.80
Pseudopodia of choriocapillary endothelium. Jpn J Ophthalmol (1989) 0.80
Scanning electron microscopic observation of Bruch's membrane with the osmium tetroxide treatment. Br J Ophthalmol (1989) 0.78
Cellular expression of tropoelastin mRNA splice variants. Matrix (1992) 0.78
Predilection of the macular region to high incidence of choroidal neovascularization after intense laser photocoagulation in the monkey. Arch Ophthalmol (2004) 0.77
[Modification of the elastic tissue of Bruch's membrane in the macular region as a function of age]. Bull Mem Soc Fr Ophtalmol (1973) 0.77
Ultrastructure of Bruch's membrane in senile macular degeneration. Acta Ophthalmol (Copenh) (1967) 0.77
[Subretinal neovessels caused by photocoagulation]. Bull Soc Ophtalmol Fr (1988) 0.77
Choroidal neovascularization not associated with age-related macular degeneration. Optom Clin (1996) 0.76
Variation in factor B (BF) and complement component 2 (C2) genes is associated with age-related macular degeneration. Nat Genet (2006) 8.33
A role for local inflammation in the formation of drusen in the aging eye. Am J Ophthalmol (2002) 5.57
Seven new loci associated with age-related macular degeneration. Nat Genet (2013) 3.81
The pivotal role of the complement system in aging and age-related macular degeneration: hypothesis re-visited. Prog Retin Eye Res (2009) 3.40
Bbs2-null mice have neurosensory deficits, a defect in social dominance, and retinopathy associated with mislocalization of rhodopsin. Proc Natl Acad Sci U S A (2004) 3.11
New approaches to the treatment of dense deposit disease. J Am Soc Nephrol (2007) 3.02
Bardet-Biedl syndrome type 4 (BBS4)-null mice implicate Bbs4 in flagella formation but not global cilia assembly. Proc Natl Acad Sci U S A (2004) 3.01
Age-related macular degeneration--emerging pathogenetic and therapeutic concepts. Ann Med (2006) 2.99
A knockin mouse model of the Bardet-Biedl syndrome 1 M390R mutation has cilia defects, ventriculomegaly, retinopathy, and obesity. Proc Natl Acad Sci U S A (2007) 2.36
Bardet-Biedl syndrome genes are important in retrograde intracellular trafficking and Kupffer's vesicle cilia function. Hum Mol Genet (2006) 2.32
Characterization of beta amyloid assemblies in drusen: the deposits associated with aging and age-related macular degeneration. Exp Eye Res (2004) 2.32
T-cell immunoglobulin and mucin domain 1 (TIM-1) is a receptor for Zaire Ebolavirus and Lake Victoria Marburgvirus. Proc Natl Acad Sci U S A (2011) 2.12
Mkks-null mice have a phenotype resembling Bardet-Biedl syndrome. Hum Mol Genet (2005) 2.04
Y402H polymorphism of complement factor H affects binding affinity to C-reactive protein. J Immunol (2007) 2.00
Identical mutation in a novel retinal gene causes progressive rod-cone degeneration in dogs and retinitis pigmentosa in humans. Genomics (2006) 1.93
Perifoveal müller cell depletion in a case of macular telangiectasia type 2. Ophthalmology (2010) 1.92
Exome sequencing and analysis of induced pluripotent stem cells identify the cilia-related gene male germ cell-associated kinase (MAK) as a cause of retinitis pigmentosa. Proc Natl Acad Sci U S A (2011) 1.87
Copy number variations on chromosome 12q14 in patients with normal tension glaucoma. Hum Mol Genet (2011) 1.74
What does the commonly used DCF test for oxidative stress really show? Biochem J (2010) 1.67
Bestrophin gene mutations cause canine multifocal retinopathy: a novel animal model for best disease. Invest Ophthalmol Vis Sci (2007) 1.54
Single cell trapping and DNA damage analysis using microwell arrays. Proc Natl Acad Sci U S A (2010) 1.53
Systems-level analysis of age-related macular degeneration reveals global biomarkers and phenotype-specific functional networks. Genome Med (2012) 1.46
Late development of vitelliform lesions and flecks in a patient with best disease: clinicopathologic correlation. Arch Ophthalmol (2005) 1.42
Complement, age-related macular degeneration and a vision of the future. Arch Ophthalmol (2010) 1.42
Association of HLA class I and class II polymorphisms with age-related macular degeneration. Invest Ophthalmol Vis Sci (2005) 1.40
Patient-specific iPSC-derived photoreceptor precursor cells as a means to investigate retinitis pigmentosa. Elife (2013) 1.33
Gene expression analysis of photoreceptor cell loss in bbs4-knockout mice reveals an early stress gene response and photoreceptor cell damage. Invest Ophthalmol Vis Sci (2007) 1.28
Use of a synthetic xeno-free culture substrate for induced pluripotent stem cell induction and retinal differentiation. Stem Cells Transl Med (2012) 1.27
Generation, identification and functional characterization of the nob4 mutation of Grm6 in the mouse. Vis Neurosci (2007) 1.27
Non-exomic and synonymous variants in ABCA4 are an important cause of Stargardt disease. Hum Mol Genet (2013) 1.27
Complement component C5a activates ICAM-1 expression on human choroidal endothelial cells. Invest Ophthalmol Vis Sci (2010) 1.26
Automated segmentation of the choroid from clinical SD-OCT. Invest Ophthalmol Vis Sci (2012) 1.26
Autosomal recessive vitelliform macular dystrophy in a large cohort of vitelliform macular dystrophy patients. Retina (2011) 1.24
Ophthalmic drug delivery systems for the treatment of retinal diseases: basic research to clinical applications. Invest Ophthalmol Vis Sci (2010) 1.17
Vitamin D status and early age-related macular degeneration in postmenopausal women. Arch Ophthalmol (2011) 1.13
Identification and functional analysis of the vision-specific BBS3 (ARL6) long isoform. PLoS Genet (2010) 1.12
Ethnic variation in AMD-associated complement factor H polymorphism p.Tyr402His. Hum Mutat (2006) 1.12
Adeno-associated virus type 5: transduction efficiency and cell-type specificity in the primate retina. Hum Gene Ther (2003) 1.12
Chromosome 7q31 POAG locus: ocular expression of caveolins and lack of association with POAG in a US cohort. Mol Vis (2011) 1.11
Systems biology-based analysis implicates a novel role for vitamin D metabolism in the pathogenesis of age-related macular degeneration. Hum Genomics (2011) 1.08
The SERPING1 gene and age-related macular degeneration. Lancet (2009) 1.08
Three-dimensional distribution of the vitelliform lesion, photoreceptors, and retinal pigment epithelium in the macula of patients with best vitelliform macular dystrophy. Arch Ophthalmol (2011) 1.06
Structural and biochemical analyses of choroidal thickness in human donor eyes. Invest Ophthalmol Vis Sci (2014) 1.06
Retinal basement membrane abnormalities and the retinopathy of Alport syndrome. Invest Ophthalmol Vis Sci (2009) 1.06
Human photoreceptor outer segments shorten during light adaptation. Invest Ophthalmol Vis Sci (2013) 1.05
Gene transfer to the nonhuman primate retina with recombinant feline immunodeficiency virus vectors. Hum Gene Ther (2002) 1.04
Time-resolved autofluorescence imaging of human donor retina tissue from donors with significant extramacular drusen. Invest Ophthalmol Vis Sci (2012) 1.04
Variations in NPHP5 in patients with nonsyndromic leber congenital amaurosis and Senior-Loken syndrome. Arch Ophthalmol (2011) 1.04
Exon-level expression profiling of ocular tissues. Exp Eye Res (2013) 1.04
Results from screening over 9000 mutation-bearing mice for defects in the electroretinogram and appearance of the fundus. Vision Res (2004) 1.02
Subretinal gene therapy of mice with Bardet-Biedl syndrome type 1. Invest Ophthalmol Vis Sci (2013) 1.01
Reticular macular disease is associated with multilobular geographic atrophy in age-related macular degeneration. Retina (2013) 1.00
Vitreoschisis in macular diseases. Br J Ophthalmol (2010) 0.99
Altered gene expression in dry age-related macular degeneration suggests early loss of choroidal endothelial cells. Mol Vis (2013) 0.98
Geographic atrophy in age-related macular degeneration and TLR3. N Engl J Med (2009) 0.97
Convergence of linkage, gene expression and association data demonstrates the influence of the RAR-related orphan receptor alpha (RORA) gene on neovascular AMD: a systems biology based approach. Vision Res (2009) 0.95
T-cell infiltration in autosomal dominant neovascular inflammatory vitreoretinopathy. Mol Vis (2010) 0.95
Visual impairment in the absence of dystroglycan. J Neurosci (2009) 0.94
Elastin-mediated choroidal endothelial cell migration: possible role in age-related macular degeneration. Invest Ophthalmol Vis Sci (2008) 0.93
Heterozygous triplication of upstream regulatory sequences leads to dysregulation of matrix metalloproteinase 19 in patients with cavitary optic disc anomaly. Hum Mutat (2015) 0.92
Generation, characterization, and molecular cloning of the Noerg-1 mutation of rhodopsin in the mouse. Vis Neurosci (2005) 0.91
Standard fluorescent imaging of live cells is highly genotoxic. Cytometry A (2013) 0.90
Heparan sulfate, including that in Bruch's membrane, inhibits the complement alternative pathway: implications for age-related macular degeneration. J Immunol (2010) 0.89
Fibulin-5 distribution in human eyes: relevance to age-related macular degeneration. Exp Eye Res (2006) 0.89
Treating necrotizing fasciitis with or without hyperbaric oxygen therapy. Undersea Hyperb Med (2010) 0.89
Fcγ receptor upregulation is associated with immune complex inflammation in the mouse retina and early age-related macular degeneration. Invest Ophthalmol Vis Sci (2014) 0.87
Different inner retinal pathways mediate rod-cone input in irradiance detection for the pupillary light reflex and regulation of behavioral state in mice. Invest Ophthalmol Vis Sci (2011) 0.86
Pleomorphic lipoma of the orbit: a case series and review of literature. Ophthalmology (2003) 0.86
Ultrastructural and clinical evidence of subretinal debris accumulation in type 2 macular telangiectasia. Br J Ophthalmol (2012) 0.85
Influence of ROBO1 and RORA on risk of age-related macular degeneration reveals genetically distinct phenotypes in disease pathophysiology. PLoS One (2011) 0.85
Renal cell carcinoma metastasis masquerading as recurrent orbital haematoma. Orbit (2005) 0.85
Inclusion of genotype with fundus phenotype improves accuracy of predicting choroidal neovascularization and geographic atrophy. Ophthalmology (2013) 0.84
Comparison of color to fluorescein angiographic images from patients with early-adult onset grouped drusen suggests drusen substructure. Am J Ophthalmol (2004) 0.84
Fundus autofluorescence and spectral-domain optical coherence tomography characteristics in a rapidly progressing form of geographic atrophy. Invest Ophthalmol Vis Sci (2011) 0.84
Serum VEGF and CFH in exudative age-related macular degeneration. Curr Eye Res (2010) 0.84
REFRACTILE DRUSEN: Clinical Imaging and Candidate Histology. Retina (2015) 0.83
New era for personalized medicine: the diagnosis and management of age-related macular degeneration. Clin Experiment Ophthalmol (2009) 0.83
Photoreceptor cells with profound structural deficits can support useful vision in mice. Invest Ophthalmol Vis Sci (2014) 0.83
TBK1 and flanking genes in human retina. Ophthalmic Genet (2013) 0.82
Effects of antioxidant components of AREDS vitamins and zinc ions on endothelial cell activation: implications for macular degeneration. Invest Ophthalmol Vis Sci (2012) 0.82
Comparison of drusen and modifying genes in autosomal dominant radial drusen and age-related macular degeneration. Retina (2015) 0.82
Fibroblast growth factor receptor (FGFR) and candidate signaling molecule distribution within rat and human retina. Mol Vis (2002) 0.81
Seroreactivity against aqueous-soluble and detergent-soluble retinal proteins in posterior uveitis. Arch Ophthalmol (2011) 0.81
Divergent phenotypes of vision and accessory visual function in mice with visual cycle dysfunction (Rpe65 rd12) or retinal degeneration (rd/rd). Invest Ophthalmol Vis Sci (2008) 0.81
Cytoarchitecture of choroidal capillary endothelial cells. Invest Ophthalmol Vis Sci (2004) 0.81
Angiogenin in age-related macular degeneration. Mol Vis (2011) 0.80
Pilot application of iTRAQ to the retinal disease Macular Telangiectasia. J Proteome Res (2011) 0.80
Molecular responses of choroidal endothelial cells to elastin derived peptides through the elastin-binding protein (GLB1). Matrix Biol (2011) 0.80
Cadherin 5 is regulated by corticosteroids and associated with central serous chorioretinopathy. Hum Mutat (2014) 0.80
Anti-γ-enolase autoimmune retinopathy manifesting in early childhood. Arch Ophthalmol (2010) 0.79
Complement factor H: using atomic resolution structure to illuminate disease mechanisms. Adv Exp Med Biol (2008) 0.79
Basement membrane changes in capillaries of the ageing human retina. Br J Ophthalmol (2011) 0.79
Rapid and sensitive method for detection of Y402, H402, I62, and V62 variants of complement factor H in human plasma samples using mass spectrometry. Invest Ophthalmol Vis Sci (2008) 0.79
Prioritization of retinal disease genes: an integrative approach. Hum Mutat (2013) 0.79
Purpura fulminans: a case series managed at a regional burn center. J Burn Care Res (2008) 0.78
Temporal macular thinning associated with X-linked Alport syndrome. JAMA Ophthalmol (2013) 0.78
Clinical utility and economic impact of introducing a bowel management system. J Wound Ostomy Continence Nurs (2007) 0.78
Localization of SH3PXD2B in human eyes and detection of rare variants in patients with anterior segment diseases and glaucoma. Mol Vis (2012) 0.77